| Mr Ariel F Silva, NP | |
|
565 E 68th St Fl 2, New York, NY 10065-4870 | |
| (212) 746-7000 | |
| (646) 697-0029 |
| Full Name | Mr Ariel F Silva |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 565 E 68th St Fl 2, New York, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063878791 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SA2200X | Clinical Nurse Specialist - Adult Health | F307421 (New York) | Primary |
| 364SG0600X | Clinical Nurse Specialist - Gerontology | F307421 (New York) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New York-presbyterian Hospital | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Weill Medical College Of Cornell | 6800709023 | 1616 |
News Archive
Vanderbilt University hopes to enroll about 400 women in a national study to evaluate the effectiveness of a new model of group prenatal care designed to improve the health and well-being of mothers and babies during pregnancy, birth and infancy.
Colorectal surgery patients who were a part of an enhanced recovery after surgery program had less pain, while using nearly half as many opioids, according to research being presented at the ANESTHESIOLOGY 2019 annual meeting.
Alzheimer's disease (AD) progresses inside the brain in a rising storm of cellular chaos as deposits of the toxic protein, amyloid-beta (Aβ), overwhelm neurons. An apparent side effect of accumulating Aβ in neurons is the fragmentation of the Golgi apparatus, the part of the cell involved in packaging and sorting protein cargo including the precursor of Aβ. But is the destruction the Golgi a kind of collateral damage from the Aβ storm or is the loss of Golgi function itself part of the driving force behind Alzheimer's? This was the question for Yanzhuang Wang, Gunjan Joshi, and colleagues at the University of Michigan, Ann Arbor, as they set out to uncover the mechanism damaging the Golgi, using a transgenic mouse and tissue culture models of AD to look at what was going on.
U.S. Congressman Rush Holt (R-12th) visited the headquarters of VaxInnate Corporation today, where he congratulated the biotechnology company on having received a U.S. government contract to fund development of the next generation of flu vaccines and called for more technology investments to improve the health of all Americans.
Rhythm announced today the results of two Phase 1 clinical trials of RM-131, the company's novel ghrelin agonist for the treatment of diabetic gastroparesis, which demonstrated that RM-131 greatly accelerates gastric emptying in healthy subjects with good tolerability.
› Verified 1 days ago
| Entity Name | Weill Medical College Of Cornell |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669579017 PECOS PAC ID: 6800709023 Enrollment ID: O20040501000028 |
News Archive
Vanderbilt University hopes to enroll about 400 women in a national study to evaluate the effectiveness of a new model of group prenatal care designed to improve the health and well-being of mothers and babies during pregnancy, birth and infancy.
Colorectal surgery patients who were a part of an enhanced recovery after surgery program had less pain, while using nearly half as many opioids, according to research being presented at the ANESTHESIOLOGY 2019 annual meeting.
Alzheimer's disease (AD) progresses inside the brain in a rising storm of cellular chaos as deposits of the toxic protein, amyloid-beta (Aβ), overwhelm neurons. An apparent side effect of accumulating Aβ in neurons is the fragmentation of the Golgi apparatus, the part of the cell involved in packaging and sorting protein cargo including the precursor of Aβ. But is the destruction the Golgi a kind of collateral damage from the Aβ storm or is the loss of Golgi function itself part of the driving force behind Alzheimer's? This was the question for Yanzhuang Wang, Gunjan Joshi, and colleagues at the University of Michigan, Ann Arbor, as they set out to uncover the mechanism damaging the Golgi, using a transgenic mouse and tissue culture models of AD to look at what was going on.
U.S. Congressman Rush Holt (R-12th) visited the headquarters of VaxInnate Corporation today, where he congratulated the biotechnology company on having received a U.S. government contract to fund development of the next generation of flu vaccines and called for more technology investments to improve the health of all Americans.
Rhythm announced today the results of two Phase 1 clinical trials of RM-131, the company's novel ghrelin agonist for the treatment of diabetic gastroparesis, which demonstrated that RM-131 greatly accelerates gastric emptying in healthy subjects with good tolerability.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Ariel F Silva, NP 20 Metropolitan Oval, Apt 11 B, Bronx, NY 10462-6790 Ph: (917) 723-7134 | Mr Ariel F Silva, NP 565 E 68th St Fl 2, New York, NY 10065-4870 Ph: (212) 746-7000 |
News Archive
Vanderbilt University hopes to enroll about 400 women in a national study to evaluate the effectiveness of a new model of group prenatal care designed to improve the health and well-being of mothers and babies during pregnancy, birth and infancy.
Colorectal surgery patients who were a part of an enhanced recovery after surgery program had less pain, while using nearly half as many opioids, according to research being presented at the ANESTHESIOLOGY 2019 annual meeting.
Alzheimer's disease (AD) progresses inside the brain in a rising storm of cellular chaos as deposits of the toxic protein, amyloid-beta (Aβ), overwhelm neurons. An apparent side effect of accumulating Aβ in neurons is the fragmentation of the Golgi apparatus, the part of the cell involved in packaging and sorting protein cargo including the precursor of Aβ. But is the destruction the Golgi a kind of collateral damage from the Aβ storm or is the loss of Golgi function itself part of the driving force behind Alzheimer's? This was the question for Yanzhuang Wang, Gunjan Joshi, and colleagues at the University of Michigan, Ann Arbor, as they set out to uncover the mechanism damaging the Golgi, using a transgenic mouse and tissue culture models of AD to look at what was going on.
U.S. Congressman Rush Holt (R-12th) visited the headquarters of VaxInnate Corporation today, where he congratulated the biotechnology company on having received a U.S. government contract to fund development of the next generation of flu vaccines and called for more technology investments to improve the health of all Americans.
Rhythm announced today the results of two Phase 1 clinical trials of RM-131, the company's novel ghrelin agonist for the treatment of diabetic gastroparesis, which demonstrated that RM-131 greatly accelerates gastric emptying in healthy subjects with good tolerability.
› Verified 1 days ago
Mrs. Jaisa Joseph Pallickal, MSN ANP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 75 Broad St, 0815, New York, NY 10004 Phone: 718-391-0611 | |
Oliver Pulido, ANP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: One Penn Plaza, 7th Floor, Suite 725, New York, NY 10119 Phone: 917-238-6698 | |
Ms. Laura Kleinerman, MS RN Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 156 West 86th Street, 1c, New York, NY 10024 Phone: 212-874-2417 | |
Allegra Dacosta-wald, Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 530 E 74th St, New York, NY 10021 Phone: 917-477-9594 | |
Ms. Aileen J. Song, A.P.N. Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 100 E 77th St, New York, NY 10075 Phone: 212-434-2565 | |
Joseph Barbicas, N.P. Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 75 Maiden Ln, Suite 1206, New York, NY 10038 Phone: 212-995-6495 Fax: 212-844-6772 |